Min Hee Hong

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Chun‐Gon Kim, Kyoung‐Ho Kim, Kyoung‐Ho Pyo et al. · Annals of Oncology · 2019 · 296 citations · Full text

Pd-1/pd-l1 Blockade, Non-small-cell Lung Cancer, Advanced Lung Disease +9

Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer

Jae-Won Cho, Min Hee Hong, Sang‐Jun Ha et al. · Experimental & Molecular Medicine · 2020 · 276 citations · Full text

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion–Driven NSCLC

Jiyeon Yun, Soo‐Hwan Lee, Seok‐Young Kim et al. · Cancer Discovery · 2020 · 272 citations · Full text

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

Hye Ryun Kim, Sang‐Jun Ha, Min Hee Hong et al. · Scientific Reports · 2016 · 257 citations · Full text

Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody

James J. Harding, Víctor Moreno, Yung‐Jue Bang et al. · Clinical Cancer Research · 2021 · 155 citations · Full text